Carla Piano1, Francesco Bove2, Delia Mulas1,3, Anna Rita Bentivoglio1, Beatrice Cioni4, Tommaso Tufo4. 1. Institute of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168, Rome, Italy. 2. Institute of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168, Rome, Italy. francescobove86@gmail.com. 3. Institute of Neurology, Mater Olbia Hospital, Olbia, Italy. 4. Institute of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Abstract
BACKGROUND: In most centers, the surgery of deep brain stimulation (DBS) is performed using a stereotactic frame. Compared with frame-based technique, frameless stereotaxy reduces the duration of surgical procedure and patient's discomfort, with lead placing accuracy equivalent after the learning curve. Although several studies have investigated the targeting accuracy of this technique, only a few studies reported clinical outcomes, with data of short-term follow-up. OBJECTIVE: To assess clinical efficacy and safety of frameless bilateral subthalamic nucleus (STN) DBS in Parkinson's disease (PD) patients at 1- and 3-year follow-up. METHODS: Consecutive PD patients who underwent bilateral STN-DBS with a manual adjustable frameless system were included in the study. The data were collected retrospectively. RESULTS: Eighteen PD patients underwent bilateral STN-DBS implant and were included in the study. All patients completed 1-year observation and ten of them completed 3-year observation. At 1-year follow-up, motor efficacy of STN stimulation in off-med condition was of 30.1% (P = 0.003) and at 3-year follow-up was of 36.3%, compared with off-stim condition at 3-year follow-up (P = 0.005). Dopaminergic drugs were significantly reduced by 31.2% 1 year after the intervention (P = 0.003) and 31.7% 3 years after the intervention (P = 0.04). No serious adverse events occurred during surgery. CONCLUSIONS: Frameless stereotaxy is an effective and safe technique for DBS surgery at 1- and 3-year follow-up, with great advantages for patients' discomfort during surgery.
BACKGROUND: In most centers, the surgery of deep brain stimulation (DBS) is performed using a stereotactic frame. Compared with frame-based technique, frameless stereotaxy reduces the duration of surgical procedure and patient's discomfort, with lead placing accuracy equivalent after the learning curve. Although several studies have investigated the targeting accuracy of this technique, only a few studies reported clinical outcomes, with data of short-term follow-up. OBJECTIVE: To assess clinical efficacy and safety of frameless bilateral subthalamic nucleus (STN) DBS in Parkinson's disease (PD) patients at 1- and 3-year follow-up. METHODS: Consecutive PDpatients who underwent bilateral STN-DBS with a manual adjustable frameless system were included in the study. The data were collected retrospectively. RESULTS: Eighteen PDpatients underwent bilateral STN-DBS implant and were included in the study. All patients completed 1-year observation and ten of them completed 3-year observation. At 1-year follow-up, motor efficacy of STN stimulation in off-med condition was of 30.1% (P = 0.003) and at 3-year follow-up was of 36.3%, compared with off-stim condition at 3-year follow-up (P = 0.005). Dopaminergic drugs were significantly reduced by 31.2% 1 year after the intervention (P = 0.003) and 31.7% 3 years after the intervention (P = 0.04). No serious adverse events occurred during surgery. CONCLUSIONS: Frameless stereotaxy is an effective and safe technique for DBS surgery at 1- and 3-year follow-up, with great advantages for patients' discomfort during surgery.
Authors: Michael S Okun; Michele Tagliati; Michael Pourfar; Hubert H Fernandez; Ramon L Rodriguez; Ron L Alterman; Kelly D Foote Journal: Arch Neurol Date: 2005-06-13
Authors: Michael S Okun; Bruno V Gallo; George Mandybur; Jonathan Jagid; Kelly D Foote; Fredy J Revilla; Ron Alterman; Joseph Jankovic; Richard Simpson; Fred Junn; Leo Verhagen; Jeff E Arle; Blair Ford; Robert R Goodman; R Malcolm Stewart; Stacy Horn; Gordon H Baltuch; Brian H Kopell; Frederick Marshall; Delea Peichel; Rajesh Pahwa; Kelly E Lyons; Alexander I Tröster; Jerrold L Vitek; Michele Tagliati Journal: Lancet Neurol Date: 2012-01-11 Impact factor: 44.182
Authors: Lennart Henning Stieglitz; Jens Fichtner; Robert Andres; Philippe Schucht; Ann-Kathrin Krähenbühl; Andreas Raabe; Jürgen Beck Journal: Neurosurgery Date: 2013-05 Impact factor: 4.654
Authors: Jill L Ostrem; Nicholas B Galifianakis; Leslie C Markun; Jamie K Grace; Alastair J Martin; Philip A Starr; Paul S Larson Journal: Clin Neurol Neurosurg Date: 2012-09-01 Impact factor: 1.876
Authors: Jill L Ostrem; Nathan Ziman; Nicholas B Galifianakis; Philip A Starr; Marta San Luciano; Maya Katz; Caroline A Racine; Alastair J Martin; Leslie C Markun; Paul S Larson Journal: J Neurosurg Date: 2015-10-23 Impact factor: 5.115